colonoscopy glp 1 THE UNSEEN CONSEQUENCES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1RA) IN PATIENTS UNDERGOING UPPER ENDOSCOPY Are Serious Anesthesia Risks of

In this regard, high-quality studies are needed to provide definitive answers about who should suspend these drugs, for example, obese patients due to the fact of difficult intubation, and who should not, for example, type 2 diabetes mellitus for their cardiovascular, renal, and cerebral positive side effects

Common requirements include : Documented hemoglobin A1C of 7.5% or higher Confirmed Type 2 diabetes history Established cardiovascular disease Some states require trying two or more oral medications before approving injectable GLP-1 receptor agonists

This careful screening helps ensure safety while maximizing the potential for successful weight loss outcomes

Markers of -cell failure predict poor glycemic response to GLP-1 receptor agonist therapy in type 2 diabetes